NASDAQ:ALKS

Alkermes Stock Insider Trading

etoro logo Buy ALKS
*Your capital is at risk
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026

Alkermes Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 10.04. In total, the insiders bought 1.09M and sold 104.2K ALKS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
10.04
Buy 1.09M shares
Sell 104.2K shares
73% Buy Activity
Moderate Positive Correlation
Buy Signal Medium Confidence
Mar 02, 2026

Analysis Breakdown:

  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Buy
Ordinary Shares
M-Exempt
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Officer 5 000
Value: $96.7K
Jun 01, 2026
Sell
Ordinary Shares
S-Sale
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Officer 9 000
Value: $375.0K
Jun 01, 2026
Buy
Employee Stock Option (Right to Buy)
M-Exempt
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Officer 5 000
Value: $96.7K
May 29, 2026
Buy
Employee Stock Option (Right to Buy)
M-Exempt
Parisi Samuel Joseph
Vp, Finance (interim Pao)
Officer 12 825
Value: $248.0K
May 29, 2026
Buy
Ordinary Shares
M-Exempt
Parisi Samuel Joseph
Vp, Finance (interim Pao)
Officer 3 392
Value: $67.9K
May 29, 2026
Sell
Ordinary Shares
S-Sale
Parisi Samuel Joseph
Vp, Finance (interim Pao)
Officer 16 217
Value: $687.0K
May 29, 2026
Buy
Employee Stock Option (Right to Buy)
M-Exempt
Parisi Samuel Joseph
Vp, Finance (interim Pao)
Officer 3 392
Value: $67.9K
May 29, 2026
Buy
Ordinary Shares
M-Exempt
Parisi Samuel Joseph
Vp, Finance (interim Pao)
Officer 12 825
Value: $248.0K
May 21, 2026
Buy
Ordinary Shares
M-Exempt
Snyderman Nancy Lynn Md
Director
Director 6 142
Value: $226.9K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Snyderman Nancy Lynn Md
Director
Director 1 475
Value: $54.5K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Snyderman Nancy Lynn Md
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Ordinary Shares
M-Exempt
Mckeon Brian P
Director
Director 6 142
Value: $226.9K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Mckeon Brian P
Director
Director 1 475
Value: $54.5K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Mckeon Brian P
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Wilson Frank Anders
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Wright Christopher I
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Ordinary Shares
M-Exempt
Wilson Frank Anders
Director
Director 6 142
Value: $226.9K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Wilson Frank Anders
Director
Director 1 475
Value: $54.5K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Wright Christopher I
Director
Director 1 475
Value: $54.5K
May 21, 2026
Buy
Ordinary Shares
M-Exempt
Wright Christopher I
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Cooke Shane
Director
Director 6 142
Value: $226.9K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Cooke Shane
Director
Director 3 207
Value: $118.5K
May 21, 2026
Buy
Ordinary Shares
M-Exempt
Cooke Shane
Director
Director 6 142
Value: $226.9K
May 21, 2026
Buy
Restricted Stock Unit Award
M-Exempt
Gaynor Richard
Director
Director 6 142
Value: $226.9K
May 21, 2026
Sell
Ordinary Shares
F-InKind
Gaynor Richard
Director
Director 1 475
Value: $54.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ALKERMES PLC
Alkermes
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE